Home/Filings/4/0001144204-19-019500
4//SEC Filing

Klein Dov 4

Accession 0001144204-19-019500

CIK 0001429260other

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 4:10 PM ET

Size

8.1 KB

Accession

0001144204-19-019500

Insider Transaction Report

Form 4
Period: 2018-01-01
Klein Dov
Director
Transactions
  • Award

    Common Stock

    2018-01-01+100,000355,000 total
  • Award

    Common Stock

    2019-01-01+100,000455,000 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,800
Footnotes (3)
  • [F1]One-third of the shares will vest on each of January 1, 2019, 2020, and 2021, subject to continued service. The reporting person elected to defer 80,000 of these shares pursuant to the issuer's Deferred Compensation Plan for Directors. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or a change in control
  • [F2]The total holdings include 53,332 shares underlying deferred restricted stock units that were previously reported in Table II.
  • [F3]One-third of the shares will vest on each January 1, 2020, 2021 and 2022, subject to continued service. The reporting person elected to defer 80,000 of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001647971

Filing Metadata

Form type
4
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:10 PM ET
Size
8.1 KB